Back to FARALLON CAPITAL MANAGEMENT, L.L.C.

BEAM
Showing 8 of 21 quarters

Position history for FARALLON CAPITAL MANAGEMENT, L.L.C.'s holdings in BEAM THERAPEUTICS INC

FARALLON CAPITAL MANAGEMENT, L.L.C. holds 10.1M shares of BEAM (BEAM THERAPEUTICS INC), worth $241.5M as of 2026-Q1. The position was increased (+0.7% shares). BEAM represents 1.4% of FARALLON CAPITAL MANAGEMENT, L.L.C.'s portfolio.

Current Value

$241.5M

Current Shares

10.1M

Total Value Change

+$56.1M

Total Shares Change

+2.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
10.1M
+0.7%
$241.5M1.4%$27.22
49
2025-Q4
Unchanged
10.1M
0.0%
$278.9M1.3%$27.82
0
2025-Q3
Increased
10.1M
+0.5%
$244.2M1.0%$23.91
43
2025-Q2
Increased
10M
+0.9%
$170.3M0.7%$16.80
43
2025-Q1
Increased
9.9M
+20.5%
$193.9M1.1%$22.21
57
2024-Q4
Increased
8.2M
+0.4%
$204.3M1.0%$25.27
48
2024-Q3
Increased
8.2M
+3.7%
$201.1M1.0%$25.05
45
2024-Q2
Increased
7.9M
+75.4%
$185.4M0.9%$23.43
65

Other major holders of BEAM: ARK Investment Management LLC, Temasek Holdings (Private) Ltd

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used